Thread by @BASHH_UK

Kicking off the short oral abstract session: #MiriamRingshall discussing chemsex, Doxy STI PrEP and influence of the pandemic on sex behaviour in Brighton MSM

High rates of drug use inc. chems, STIPrEP, multiple sexual partners. How does this compare to your service users? And how do you support? Apps may be helpful #vBASHH21

Next: Tia Hunjan describing possible pathophysiology of hypoactive sexual desire disorder, which is commoner in young women with an estimated prevalence of 10%

Could melanocortin-4 agonists help this debilitating issue? #vBASHH21 #HSDD

Good clinical and radiological responses on fMRI. Potential avenue for future targeted therapy development for low sexual desire in women #HSDD #VBASHH21

Next up: Dr Chan of MMC discussing outcomes and challenges faced by screening entrants to a women's prison for infections including syphilis by dried blood spot

A local syphilis outbreak amongst the women was able to be described, traced to a local sex premises, contact-traced and treated @MMC_cnwl #vBASHH21

Important work to improve #womenshealth #prisonerhealth, despite many challenges including lockdown and transient population #vBASHH21

Interesting answer to question: much discussion amongst colleagues re. benefit vs risk of waiting for an RPR before treating, and risking the woman being released from prison without treatment in that time. Decision was in favour of empirical tx without delay #vBASHH21

Now Louise Thorn comparing sources of figures for STI incidence over 2019-2020 - GUMCAD vs CTAD

Now that lockdown measures have been lifted, STI rates are increasing again - but not to pre-pandemic levels (caveat: some may be underrepresented eg. shigella, and online testing results excluded) #vBASHH21

Freddy Green on syphilis testing trends among MSM during COVID: we know that increased testing is key to reversing rising rates of infection we're seeing